ResearcherSeoul National UniversityNo recent work listed
Jinkook Kim
Matched on ORCID iD 0000-0002-8455-9711; OpenAlex author ID A5019952613. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2020: 2 papers · 2021: 1 paper
Papers 3
- Gender Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX. Co-author DOI 10.3390/jpm11020083↗
- Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry. Co-author DOI 10.1097/coc.0000000000000730↗
- Sex Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX Co-author DOI 10.21203/rs.3.rs-33720/v1↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin Won Kim · 3 shared papers, 2020–2021 · strength 0.36
- Paper Gender Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX. DOI 10.3390/jpm11020083↗
- Paper Sex Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX DOI 10.21203/rs.3.rs-33720/v1↗
- Paper Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korea… DOI 10.1097/coc.0000000000000730↗
- Jin‐Hyeok Hwang · 3 shared papers, 2020–2021 · strength 0.36
- Paper Gender Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX. DOI 10.3390/jpm11020083↗
- Paper Sex Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX DOI 10.21203/rs.3.rs-33720/v1↗
- Paper Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korea… DOI 10.1097/coc.0000000000000730↗
- Kwangrok Jung · 2 shared papers, 2020–2021 · strength 0.26
- Jong-Chan Lee · 2 shared papers, 2020 · strength 0.21
- Jaihwan Kim · 2 shared papers, 2020 · strength 0.21
- Dong Woo Shin · 1 shared paper, 2020 · strength 0.10
- Woo Jin Lee · 1 shared paper, 2020 · strength 0.10
- Sang Myung Woo · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.